| Elizabeth Mogtader, | |
|
570 Bartram Rd, Moorestown, NJ 08057-1871 | |
| (609) 923-3285 | |
| Not Available |
| Full Name | Elizabeth Mogtader |
|---|---|
| Gender | Female |
| Speciality | Clinical Nurse Specialist - Psychiatric/mental Health, Child & Adolescent |
| Location | 570 Bartram Rd, Moorestown, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598294076 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SP0807X | Clinical Nurse Specialist - Psychiatric/mental Health, Child & Adolescent | 26NJ00113300 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Elizabeth Mogtader, 570 Bartram Rd, Moorestown, NJ 08057-1871 Ph: (609) 923-3285 | Elizabeth Mogtader, 570 Bartram Rd, Moorestown, NJ 08057-1871 Ph: (609) 923-3285 |
News Archive
Today, Cephalon, Inc. announced the signing of a convertible note subscription agreement with ChemGenex Pharmaceuticals Limited, an Australian-based oncology focused biopharmaceutical company.
Depomed, Inc. announced today it has received guidance from the FDA in formal meeting minutes from a meeting held in December regarding SeradaTM, the company's extended release gabapentin product candidate for the treatment of menopausal hot flashes. Based on guidance reflected in the meeting minutes, Depomed plans to conduct a single additional pivotal Phase 3 trial evaluating Serada for the treatment of menopausal hot flashes.
A test that measures how quickly cells are dividing is an accurate way for doctors to predict the aggressiveness of breast cancer tumors, even among women with very early stages of the disease, researchers told the 2nd ESMO Scientific & Educational Conference (ESEC) in Budapest, Hungary.
The mental health of children and young people with some long term physical conditions could benefit from cognitive behavioral therapy, according to a recent study from the University of Exeter Medical School.
Zynex, Inc., a provider of pain management systems and electrotherapy products for medical patients with functional disability, announces it has signed a lease to rent a 75,000-square-foot building in Lone Tree (Littleton), Colorado. Zynex currently leases 16,553 square feet in Littleton, Colorado and the new building will house its headquarters, office, plant and warehouse.
› Verified 6 days ago